Skip to main content
NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
13.67
-0.08 (-0.58%)
At close: Feb 27, 2026, 4:00 PM EST
13.60
-0.07 (-0.51%)
After-hours: Feb 27, 2026, 7:10 PM EST

NovoCure Revenue

In the year 2025, NovoCure had annual revenue of $655.35M with 8.28% growth. NovoCure had revenue of $174.35M in the quarter ending December 31, 2025, with 8.11% growth.

Revenue (ttm)
$655.35M
Revenue Growth
+8.28%
P/S Ratio
2.37
Revenue / Employee
$440,425
Employees
1,488
Market Cap
1.56B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025655.35M50.13M8.28%
Dec 31, 2024605.22M95.88M18.82%
Dec 31, 2023509.34M-28.50M-5.30%
Dec 31, 2022537.84M2.81M0.53%
Dec 31, 2021535.03M40.66M8.23%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AdaptHealth 3.24B
QuidelOrtho 2.73B
Enovis 2.25B
CONMED 1.37B
Tandem Diabetes Care 1.01B
Inspire Medical Systems 911.98M
UFP Technologies 602.80M
Artivion 441.33M
Revenue Rankings

NVCR News

More News